help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 11, 2008
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-2294
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1649    most recent
Author Manuscript (PDF)
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lind van Wijngaarden, R. F.A.
Right arrow Articles by Hokken-Koelega, A. C.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lind van Wijngaarden, R. F.A.
Right arrow Articles by Hokken-Koelega, A. C.S.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology
Right arrow Obesity

Submitted on October 15, 2007
Accepted on February 19, 2008

High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome

Roderick F.A. de Lind van Wijngaarden M.Sc.*, Barto J. Otten M.D., Ph.D., Dederieke A.M. Festen M.D., Koen F.M. Joosten M.D., Ph.D., Frank H. de Jong M.Sc., Ph.D., Fred C.G.J. Sweep M.Sc., Ph.D., and Anita C.S. Hokken-Koelega M.D., Ph.D.

Dutch Growth Research Foundation, Rotterdam, The Netherlands; Erasmus University Medical Center / Sophia Children's Hospital, Department of Pediatric Endocrinology, Rotterdam, The Netherlands; Radboud University Nijmegen Medical Center, Department of Pediatric Endocrinology, Nijmegen, The Netherlands; Erasmus University Medical Center / Sophia Children's Hospital, Department of Pediatric Intensive Care, Rotterdam, The Netherlands; Erasmus University Medical Center, Department of Internal Medicine, Laboratory of Endocrinology, Rotterdam, The Netherlands; Radboud University Nijmegen Medical Center, Department of Chemical Endocrinology, Nijmegen, The Netherlands

* To whom correspondence should be addressed. E-mail: r.delindvanwijngaarden{at}erasmusmc.nl.

Context The annual death rate of PWS patients is very high (3%). Many of these deaths are sudden and unexplained.

Objective Because most deaths occur during moderate infections and PWS patients suffer from various hypothalamic insufficiencies, we investigated if PWS patients suffer from central adrenal insufficiency (CAI) during stressful conditions.

Design Overnight single-dose metyrapone tests were performed. Metyrapone (30 mg/kg) was administered at 2330 h. At 0400, 0600 h and 0730 h, ACTH, 11-deoxycortisol, cortisol and glucose levels were measured. Diurnal salivary cortisol profiles were assessed on a different day at wake-up, 30 minutes after wake-up, 1400 h and 2000 h.

Setting Pediatric Intensive Care Unit.

Patients 25 randomly selected PWS patients.

Main outcome measure Patients were considered as having CAI when ACTH levels remained below 33 pmol/l at 0730 h.

Results Median (inter-quartile range) age was 9.7 (6.8–13.6) years. Fifteen patients (60%) had an insufficient ACTH response (CAI, p<0.001). There was no significant difference in age, gender, genotype and BMI SDS between patients with CAI and those without. Morning salivary cortisol levels and diurnal profiles were normal in all children, suggesting that CAI becomes apparent only during stressful conditions.

Conclusions Strikingly, 60% of our PWS patients had central adrenal insufficiency. The high percentage of CAI in PWS patients might explain the high rate of sudden death in these patients, particularly during infection-related stress. Based on our data, one should consider treatment with hydrocortisone during acute illness in PWS patients, unless CAI has recently been ruled out with a metyrapone test.


Key words: Prader-Willi syndrome • children • sudden death • adrenal insufficiency • metyrapone test • cortisol




This article has been cited by other articles:


Home page
NEJMHome page
S. R. Bornstein
Predisposing Factors for Adrenal Insufficiency
N. Engl. J. Med., May 28, 2009; 360(22): 2328 - 2339.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. M Delemarre, B. Felius, and H. A Delemarre-van de Waal
Inducing puberty
Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S9 - S15.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Interpreting central adrenal insufficiency in PWS
Aaron L. Carrel, et al.
JCEM Online, 22 Jun 2008 [Full text]
Interpreting central adrenal insufficiency in PWS
Roderick F.A. de Lind van Wijngaarden, et al.
JCEM Online, 29 Aug 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society